D'Couto Helen, Thielking Acadia M, Sewpaul Ronel, Levy Douglas E, Rigotti Nancy A, Chrysanthopoulou Stavroula A, Siedner Mark J, Freedberg Kenneth A, Wood Robin, Hyle Emily P, Reddy Krishna P
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.
BMJ Glob Health. 2024 Dec 15;9(12):e017049. doi: 10.1136/bmjgh-2024-017049.
With declining HIV-related mortality, over 20% of people with HIV (PWH) in South Africa are now over age 50 years, and tobacco-related non-communicable disease burden is increasing. We quantified the impact of smoking and smoking cessation on lung cancer and stroke incidence among PWH in South Africa.
Using a microsimulation model, we simulated 18 cohorts of initially virologically suppressed PWH over their lifetime, categorised by sex, initial age (35 years/45 years/55 years) and smoking status (current/former/never). Smoking status remains constant throughout the simulation; individuals with former smoking status quit at model start. PWH can disengage from HIV care and experience virological rebound. We modelled the relative risk of lung cancer for females (males) with current versus never smoking status as 16.69 (15.83), and for females (males) with former versus never smoking status as 1.99-8.80 (1.90-6.18), depending on age at cessation. Corresponding modelled relative risks of stroke were 1.79 (1.54) for current versus never smoking, and 1.00-1.29 (1.00-1.12) for former versus never smoking. We varied HIV-related and smoking-related parameters in sensitivity analyses.
Modelled female (male) PWH who stop smoking at age 45 years experience 61.3% (70.9%) and 35.6% (18.6%) lower cumulative lung cancer and stroke incidence over 25 years compared with people who continue smoking. The proportion alive and lung cancer-free or alive and stroke-free over 25 years would increase by 10.4 (9.5) or 10.5 (8.5) percentage points. In sensitivity analysis, smoking and smoking cessation have a greater impact on lung cancer and stroke cumulative incidence if competing HIV-related mortality risks are lower or if PWH experience higher lung cancer and stroke risk compared with people without HIV apart from smoking.
Smoking cessation could substantially reduce lung cancer and stroke risk among PWH in South Africa. To reduce the rising non-communicable disease burden among PWH, smoking cessation should become part of routine care of PWH.
随着与艾滋病相关的死亡率下降,南非超过20%的艾滋病病毒感染者(PWH)年龄现已超过50岁,且与烟草相关的非传染性疾病负担正在增加。我们对吸烟和戒烟对南非艾滋病病毒感染者肺癌和中风发病率的影响进行了量化。
我们使用微观模拟模型,对18组最初病毒学抑制的艾滋病病毒感染者的一生进行模拟,按性别、初始年龄(35岁/45岁/55岁)和吸烟状况(当前吸烟者/曾经吸烟者/从不吸烟者)进行分类。在整个模拟过程中吸烟状况保持不变;曾经吸烟的个体在模型开始时戒烟。艾滋病病毒感染者可能脱离艾滋病护理并经历病毒学反弹。我们将当前吸烟与从不吸烟的女性(男性)患肺癌的相对风险建模为16.69(15.83),曾经吸烟与从不吸烟的女性(男性)患肺癌的相对风险建模为1.99 - 8.80(1.90 - 6.18),具体取决于戒烟时的年龄。当前吸烟与从不吸烟的中风相对风险建模为1.79(1.54),曾经吸烟与从不吸烟的中风相对风险建模为1.00 - 1.29(1.00 - 1.12)。我们在敏感性分析中改变了与艾滋病相关和与吸烟相关的参数。
与继续吸烟的人相比,模拟的45岁戒烟的女性(男性)艾滋病病毒感染者在25年内患肺癌和中风的累积发病率分别降低61.3%(70.9%)和35.6%(18.6%)。25年内存活且无肺癌或存活且无中风的比例将增加10.4(9.5)或10.5(8.5)个百分点。在敏感性分析中,如果与艾滋病相关的竞争死亡风险较低,或者与未感染艾滋病(除吸烟外)的人相比,艾滋病病毒感染者患肺癌和中风的风险较高,那么吸烟和戒烟对肺癌和中风累积发病率的影响更大。
戒烟可大幅降低南非艾滋病病毒感染者患肺癌和中风的风险。为减轻艾滋病病毒感染者中不断上升的非传染性疾病负担,戒烟应成为艾滋病病毒感染者常规护理的一部分。